1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SEPTERNA INC.

Septerna Inc.

XNAS: SEPN

Download real time

6.24 -0.10 (-1.58%)

77.37% Fall from 52W High

276.5K XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
4S
10W
4O
0T
277.1

Market Cap

Below industry Median
-

PE TTM

-

PEG TTM

-3.2

Price to Book

Negative Price to Book
-

Beta 1Year



Insider Trading disclosures for Septerna Inc.

The latest disclosure was made by Alan Ezekowitz in Septerna Inc. where a trade of 13,319 Common Stock done at an average price of $6.9 was reported to US exchanges on March 7, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alan Ezekowitz Director Purchase of securities on an exchange or from another person at price $ 6.93 per share. 07 Mar 2025 13,319 117,420 - 6.9 92,270 Common Stock
Alan Ezekowitz Director Purchase of securities on an exchange or from another person at price $ 5.82 per share. 04 Mar 2025 37,835 62,746 - 5.8 220,260 Common Stock
Alan Ezekowitz Director Purchase of securities on an exchange or from another person at price $ 6.35 per share. 04 Mar 2025 7,491 24,911 - 6.3 47,544 Common Stock
Alan Ezekowitz Director Purchase of securities on an exchange or from another person at price $ 6.00 per share. 04 Mar 2025 41,355 104,101 - 6 248,130 Common Stock
Gil M. Labrucherie Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 5.59 per share. 25 Feb 2025 6,282 36,282 - 5.6 35,116 Common Stock
Gil M. Labrucherie Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 5.85 per share. 25 Feb 2025 3,718 40,000 - 5.8 21,750 Common Stock
Jeffrey T. Finer Director, CEO and President Purchase of securities on an exchange or from another person at price $ 5.68 per share. 25 Feb 2025 10,000 764,907 - 5.7 56,765 Common Stock
Jeffrey T. Finer Director, CEO and President Purchase of securities on an exchange or from another person at price $ 5.70 per share. 25 Feb 2025 4,000 768,907 - 5.7 22,796 Common Stock
Jeffrey T. Finer Director, CEO and President Purchase of securities on an exchange or from another person at price $ 5.80 per share. 25 Feb 2025 3,000 771,907 - 5.8 17,400 Common Stock
Gil M. Labrucherie Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 5.51 per share. 19 Feb 2025 10,500 10,500 - 5.5 57,813 Common Stock
Gil M. Labrucherie Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 5.88 per share. 19 Feb 2025 14,500 25,000 - 5.9 85,234 Common Stock
Gil M. Labrucherie Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 5.85 per share. 19 Feb 2025 5,000 30,000 - 5.9 29,250 Common Stock
Gil M. Labrucherie Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 222,000 222,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters